Status:
COMPLETED
Study to Investigate the Effect of Deferasirox on the Pharmacokinetics of Midazolam
Lead Sponsor:
Novartis
Conditions:
Healthy
Eligibility:
All Genders
18-45 years
Phase:
PHASE1
Brief Summary
This is a study to investigate the pharmacokinetics of deferasirox
Eligibility Criteria
Inclusion
- Good health
- No evidence of iron deficiency
- Weight between 50 and 100 kg
- Body Mass Index between 19 and 29 kg/m2
Exclusion
- Use of certain drugs, herbal remedies or nutrients
- Other protocol-defined inclusion/exclusion criteria may apply
Key Trial Info
Start Date :
July 1 2006
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT00427505
Start Date
July 1 2006
Last Update
November 19 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.